tirzepatide class action lawsuit Novo Nordisk filed a against Eli Lilly & Co. accusing the manufacturer of weight-loss drug Zepbound of deceptive advertising for allegedly comparing high doses of its drug to low doses of FDA Drug Recalls and Warnings:

The pivotal STEP-1 trial reported approximately 14.9 percent mean body weight loss at 68 weeks on semaglutide

issued a recall of one lot of MyoWhey Chocolate Cookie Crunch protein powder because it may contain undeclared milk and soy

If you have a high-stakes presentation or a busy travel day, you may want to move your injection day to ensure your peak window falls on a quieter day

[2] Clinical trials show Wegovy can help you lose an average of 15% of your body weight in 68 weeks, in combination with a healthy diet and physical activity

Efficacy for weight loss is substantially lower than injectable semaglutide or tirzepatide